Imatinib-tablets

Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent. Imatinib is used for these conditions: Aggressive systemic mastocytosis (ASM)   In the imatinib group, the cumulative rate of major cytogenetic response at the end of the trial was 89.0%, and the rate of complete cyto-genetic response at the end of the trial was 82.8% (Table S10 in the Supplementary Appendix).